The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Merck & Co.'s 2013 sales performance.
US Supreme Court rejects Merck’s appeal over patent dispute verdict of $2.54bn. ... Merck &Co’s appeal to restore a verdict against Gilead for infringing on a patent relating to a hepatitis C virus (HCV) treatment has been rejected by the US Supreme
If Opdivo wins an approval for first-line gastric cancer, it could gain an advantage over Merck &Co’s (MSD) rival checkpoint inhibitor Keytruda (pembrolizumab).
In a statement, Merck said that the study’s Independent Data Monitoring Committee (IDMC) recommended that the trial should be discontinued, as it is ‘unlikely’ to meet the co-primary endpoint ... program,” said Danny Bar-Zohar, global head of
commented David Eyre, co-leader of the study and associate professor at Oxford’s Big Data Institute and Nuffield Department of Population Health.
Similarly, Novartis formed the investment firm Novartis Venture Funds and Merck &Co. ... created the Merck Research Venture Fund. Nowadays, having a venture arm to proactively research for outside R&D sourcing is common for most mid- to large- sized
The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in...